Replies to post #116680 on Innovation Pharmaceuticals Inc (IPIX)

[frrol]

A P2 renal cancer trial at BID would be a great signal. Even better would be a proposed P2 at DF with the current investigators. Either, especially both, would show Harvard is really excited by what they saw in the P1.

[To infinity and beyond!]

Just today there is an article touting a new pancreatic CA therapy that shows 4.9 months of progression free survival. Yes I would hope for much more from K but as noted(over and over, I know) responses at low doses is surprising